Core Viewpoint - Huayang New Materials (600281) experienced a significant increase in stock price, reaching the daily limit, with a trading volume of 3.81 billion yuan and a turnover rate of 11.41% [2] Group 1: Stock Performance - The stock's price deviation reached 10.57%, leading to its listing on the Shanghai Stock Exchange's watchlist [2] - The stock has been listed on the watchlist 11 times in the past six months, with an average price increase of 0.81% the day after being listed and an average decline of 4.51% over the following five days [2] Group 2: Trading Data - The top five trading departments accounted for a total transaction amount of 1.16 billion yuan, with net buying of 592.29 million yuan [2] - The largest buying department was Changjiang Securities, with a purchase amount of 32.80 million yuan, while the largest selling department was Guotai Haitong Securities, with a selling amount of 10.43 million yuan [3] Group 3: Financial Performance - For the first three quarters, the company reported a revenue of 326 million yuan, representing a year-on-year growth of 31.10%, and a net profit of 68.88 million yuan, reflecting a year-on-year increase of 178.58% [3]

证券代码：600281 证券简称：华阳新材 公告编号：2025-071 山西华阳新材料股份有限公司 关于控股股东与实际控制人之间 产权层级减少的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责 任。 本次划转后，公司的股权控制关系如下图所示： 2.本次控股股东与实际控制人之间产权层级减少不会导致公司直接控 股股东及实际控制人发生变化。公司直接控股股东仍为太化集团，实际控 制人仍为山西省国资委。 3.本次控股股东与实际控制人之间产权层级减少不涉及要约收购。 一、本次控股股东与实际控制人之间产权层级减少的基本情况 近日，公司收到控股股东太化集团转来的《山西省人民政府国有资产 监督管理委员会关于将山西省国有资本运营有限公司持有的相关企业国有 股权划转至省国资委的通知》（晋国资产权[2025]75 号），根据文件要求， 山西省人民政府决定将山西国资运营公司所持有的太化集团 100%股权划 转至山西省国资委直接持有。目前，上述事项尚未完成工商变更登记。 本次划转前，公司的股权控制关系如下图所示： 重要内容提示： 1.本次控股股东与 ...

山西华阳新材料股份有限公司 2025 年第六次临时股东会会议资料 二零二五年十二月 会议资料目录 | 一、山西华阳新材料股份有限公司 2025 年第六次临时股东会会议须知 - 1 - | | --- | | 二、山西华阳新材料股份有限公司 2025 年第六次临时股东会表决办法 - 1 - | | 三、山西华阳新材料股份有限公司 2025 年第六次临时股东会议案 - 3 - | | 1.关于太原华盛丰贵金属材料有限公司申请流动资金借款并为其提供担保的议案- 4 - | | 2.关于补选公司第八届董事会非独立董事的议案 - 7 - | 山西华阳新材料股份有限公司 2025 年第六次临时股东会会议须知 为维护公司全体股东的合法权益，确保 2025 年第六次临时股东会（以下简称"本次 会议"） 的正常秩序和议事效率，保证本次会议的顺利进行，根据中国证券监督管理委 员会发布的《上市公司股东会规则》和《山西华阳新材料股份有限公司章程》《山西华 阳新材料股份有限公司股东会议事规则》的规定，特制定以下规定： 一、现场会议要求 （一）公司负责本次会议的程序安排和会务工作，出席会议人员应当听从公司工作 人员安排，共同维护本次会议 ...

证券代码：600281 证券简称：华阳新材 公告编号：2025-069 山西华阳新材料股份有限公司 关于聘任公司总经理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 山西华阳新材料股份有限公司（以下简称"公司"）于 2025年11月19日召开了第八届董事会2025年第十 次会议，审议通过了《关于聘任公司总经理的议案》，公司董事会同意聘任景红升先生（简历附后）为 公司总经理。总经理任期自本次董事会审议通过之日起至第八届董事会届满之日止。 公司独立董事对聘任公司总经理发表了独立的意见，详见公司同日的上网文件。 特此公告。 山西华阳新材料股份有限公司董事会 2025年11月20日 景红升先生简历： 景红升，1984 年4月出生，中共党员，大学本科学历。曾任阳煤国贸上海投资公司副经理；和顺化工计 划财务部部长；阳煤集团财务部资本运营科科长；山西华阳新材料股份有限公司董事、董事会秘书、监 事会主席等职。 证券代码：600281 证券简称：华阳新材 公告编号：2025-066 山西华阳新材料股份有限公司关于向太原农商行申请流动资金 ...

11月20日，山西华阳新材料股份有限公司（以下简称"华阳新材"）发布公告称，公司董事会审议通过了 《关于聘任公司总经理的议案》，同意聘任景红升先生为公司总经理。 据公开信息，景红升，生于1984年4月出生，中共党员，大学本科学历。景红升曾先后任北京国阳新能 国际贸易有限公司财务经理，阳泉煤业集团上海投资有限公司副总经理；阳煤集团和顺化工有限公司计 划财务 部部长，阳煤集团金融（资本）运营部资本运营科科长，华阳新材董事、董事会秘书等职，现 任还是太化集团法务总监、法律事务部部长。在本次履新华阳新材总经理前，景红升为华阳新材监事会 主席。 据2024年年报信息，景红升从公司获得的税前报酬总额为2.98万元。 此前，华阳新材总经理由武跃华担任，其生于1970年1月，山西省盂县人。不过在今年11月10日，武跃 华因工作变动原因申请辞去公司董事、总经理、提名委员会委员等职务。2024年，武跃华从公司获得的 税前报酬总额为57.11万元。 华阳新材前身是太化股份，是太化集团于1998年以其下属化肥厂、化工厂、焦化厂等资产重组设立，于 2000年11月登陆资本市场，现华阳新材为华阳集团新材料业务资产整合上市平台。今年前三季 ...

（文章来源：证券日报） 证券日报网讯 11月19日晚间，华阳新材发布公告称，公司控股股东太原化学工业集团有限公司提名景 红升先生为公司第八届董事会非独立董事候选人。 ...

Core Viewpoint - Huayang New Materials announced plans to apply for a working capital loan of 196 million yuan from Taiyuan Rural Commercial Bank, with a term of three years and an expected annual interest rate not exceeding 3.8% [1] Group 1 - The loan amount is set at 196 million yuan [1] - The loan will have a term of three years [1] - The expected annual interest rate for the loan is not to exceed 3.8% [1] Group 2 - The loan will be guaranteed by Taiyuan Chemical Industry Group Real Estate Development Co., Ltd. [1]

Core Viewpoint - The company is currently operating normally and is focused on improving its revenue and profitability through various measures, despite facing challenges in its main business areas of precious metal recovery and PBAT biodegradable materials [2][3][4]. Group 1: Company Performance - The company reported a net gain of 119.32 million yuan from the transfer of land use rights to Taihua Group and received 5 million yuan in land transfer subsidy from the Taiyuan Municipal Finance Bureau [4]. - The company is implementing strategies to enhance production efficiency and reduce costs, including increasing production batch sizes and establishing long-term partnerships with key suppliers [3][4]. Group 2: Business Strategy - The company aims to innovate in the precious metal recovery industry and expand its product line, focusing on secondary resource recovery and precious metal compounds to stabilize and enhance profitability [4]. - Future asset disposal plans will be disclosed in accordance with the Shanghai Stock Exchange regulations [3]. Group 3: Environmental and Social Responsibility - The company adheres strictly to environmental regulations and publishes annual environmental or ESG reports, detailing energy consumption, emissions, and management data [4]. - Employee health and safety are prioritized, with strict safety production regulations and training systems in place [4]. Group 4: Dividend Policy - The company has not distributed dividends in recent years due to negative cumulative profits available for distribution to shareholders, but it is committed to improving profitability to eventually reward investors [5].

Group 1 - Kanglongda's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 4.83 million shares [1] - The company specializes in the research, production, and sales of special and ordinary labor protection gloves [1] Group 2 - Haizheng Pharmaceutical's subsidiary plans to collaborate with East China Institute on a biological method for synthesizing heparin, with a project contract amount not exceeding 120 million yuan [2] - The company focuses on the research, production, and sales of chemical raw materials and formulations [3] Group 3 - Tianyin Holdings received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [4] - The company is engaged in the sales of smart terminals, e-commerce, lottery, mobile resale, and mobile internet businesses [4] Group 4 - Shanghai Yashi plans to use up to 200 million yuan of temporarily idle raised funds for cash management in high-security, liquid deposit products [5] - The company specializes in supply chain logistics and execution trade [6] Group 5 - Parker New Materials intends to use 130 million yuan of idle raised funds to purchase structured deposits with expected annual yields between 0.59% and 2.9001% [7] - The company focuses on the research, production, and sales of various types of ring forgings, free forgings, and die forgings [7] Group 6 - Huayang New Materials appointed Jing Hongsheng as the new general manager [8] Group 7 - Liyuan Technology's shareholder plans to reduce holdings by up to 2.03% of the company's shares, totaling no more than 3.04 million shares [9] - The company specializes in the research, design, and integration of environmental water treatment systems and hydrogen fuel cell engine systems [9] Group 8 - Shengnuo Biopharmaceutical's subsidiary received approval for the listing application of Visepegenatide raw materials, a GLP-1 receptor agonist for treating type 2 diabetes and obesity [10][11] - The company focuses on the research, production, and sales of peptide raw materials and formulations [10] Group 9 - Puluo Pharmaceutical plans to repurchase shares worth between 180 million and 360 million yuan, with a maximum price of 23 yuan per share [12] - The company specializes in the research, production, and sales of raw material intermediates and innovative drugs [12] Group 10 - Dongfang Electric's subsidiary plans to establish a joint venture with Anhui Waneng Energy, with a registered capital of approximately 1.857 billion yuan [13] - The company is involved in the development, design, manufacturing, and sales of advanced power generation equipment [13] Group 11 - Hefei China announced that its stock will resume trading on November 20 after completing a review of abnormal trading fluctuations [14] - The company focuses on international trade and after-sales services related to in vitro diagnostic medical devices [14] Group 12 - Dafeng Industrial won a bid for the stage equipment project of the Shenzhen International Performing Arts Center, with a contract amount of 165 million yuan [15] - The company specializes in cultural sports equipment, digital art technology, and operation services [15] Group 13 - Baiyunshan's subsidiary received a drug registration certificate for An Gong Niu Huang Wan in Vietnam [16] - The company is engaged in the research, manufacturing, and sales of traditional Chinese and Western medicines [16] Group 14 - Neusoft Group received a notification to supply intelligent cockpit domain controllers for multiple models from a well-known domestic automobile manufacturer, with an estimated total amount of about 4.2 billion yuan [17] - The company focuses on providing industry solutions and software products [17] Group 15 - Huayu Pharmaceutical's product received overseas marketing approval [18] - The company specializes in the research, production, and sales of innovative and high-quality generic drugs in the oncology field [18] Group 16 - Yao Pi Glass received approval from the CSRC for its stock issuance to specific investors [19] - The company specializes in the production and sales of float glass and processed glass [19] Group 17 - Guangyu Yuan's vice president Wang Junbo resigned due to work adjustments [20] - The company focuses on the production and sales of traditional Chinese medicine products [20] Group 18 - Biyi Co. received approval from the CSRC for its stock issuance to specific investors [21] - The company specializes in the design, manufacturing, and sales of smart small household appliances [21] Group 19 - Sunshine Nuohe's application for acquiring 100% equity of Jiangsu Langyan Life Science Technology Co., Ltd. through share issuance and convertible bonds has been accepted by the Shanghai Stock Exchange [22] - The company provides comprehensive drug research and development services for domestic pharmaceutical enterprises and research institutions [22] Group 20 - Longxin General plans to increase capital in its wholly-owned subsidiary by no more than 1.65 billion yuan [23] - The company specializes in the research, production, and sales of motorcycles and engines [23] Group 21 - Jiekang Equipment received a corrective order from the Tianjin Securities Regulatory Bureau due to internal control deficiencies [24] - The company specializes in the research, production, and sales of nuclear biochemical safety equipment [24] Group 22 - Wantong Technology plans to raise no more than 920 million yuan through a private placement to supplement working capital [25] - The company focuses on information technology services for highways and ports [25] Group 23 - Dongshan Precision has submitted an application for H-share listing to the Hong Kong Stock Exchange [26] - The company specializes in the research, production, and sales of electronic circuit products and precision components [26] Group 24 - Yonghe Intelligent Control plans to publicly transfer 100% equity of its wholly-owned subsidiary Kunming Medical Oncology Hospital [27] - The company specializes in water and heating valve fittings, tumor precision radiation therapy, and photovoltaic battery businesses [27] Group 25 - Aok Shares signed a strategic cooperation framework agreement with Suzhou Qitian New Materials Co., Ltd. [28] - The company focuses on the research and production of high-end new materials derived from ethylene oxide and ethylene [28] Group 26 - Hongquan Technology's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 299,440 shares [29] - The company specializes in the research, production, and sales of intelligent connected products and software platform development [29] Group 27 - Shilong Industrial's controlling shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 7.2 million shares [30] - The company specializes in the research, production, and sales of chemical products [30] Group 28 - Tangrenshen decided to terminate the investment in the "Dongchong Phase III Pig Breeding Base Construction Project," reallocating the remaining funds of 78.9587 million yuan to supplement working capital [31] - The company specializes in the research, production, and sales of feed, pigs, meat products, and animal health products [31] Group 29 - Gaode Infrared's actual controller plans to reduce holdings by up to 3% of the company's shares, totaling no more than 12.8 million shares [32] - The company specializes in infrared focal plane detector chips and infrared thermal imaging systems [32] Group 30 - Kangyuan Pharmaceutical's actual controller recently increased holdings by 20,000 shares [33] - The company specializes in the research, production, and sales of pharmaceuticals [33] Group 31 - Haida Group plans to repurchase shares worth between 1 billion and 1.6 billion yuan, with a maximum price of 62.00 yuan per share [34] - The company provides overall solutions for animal husbandry [34] Group 32 - Qizhong Technology's 850 million yuan convertible bonds have been approved for listing [35] - The company specializes in advanced packaging and testing of integrated circuits [35] Group 33 - Dingyang Technology launched the new SNA5000B series vector network analyzer [36] - The company specializes in the research, production, and sales of general electronic testing and measuring instruments [36] Group 34 - Airo Energy plans to distribute a cash dividend of 0.9375 yuan per share to all shareholders [37] - The company specializes in photovoltaic energy storage systems and products [37] Group 35 - Hechuan Technology's actual controller and some directors plan to reduce holdings by up to 6% of the company's shares [38] - The company specializes in the research, production, and sales of industrial automation products [38] Group 36 - China First Heavy Industries' chairman was arrested for suspected bribery [39] - The company specializes in heavy machinery manufacturing for various industries [39] Group 37 - Lianhuan Pharmaceutical plans to invest 15 million yuan in joint research with Nanjing University for anti-thrombotic small nucleic acid drugs [40] - The company specializes in the manufacturing and sales of chemical raw materials [40] Group 38 - Anxu Biotech's shareholder plans to reduce holdings by up to 0.94% of the company's shares, totaling no more than 120,000 shares [41] - The company specializes in the research, production, and sales of POCT reagents and instruments [41] Group 39 - Yaxiang Integration's shareholder reduced holdings by 130,000 shares [42] - The company specializes in providing cleanroom engineering and related services for high-tech electronic industries [42] Group 40 - Zhongwen Media plans to use up to 9.5 billion yuan of idle funds to purchase financial products [43] - The company specializes in traditional publishing and various new media businesses [43]

Group 1 - The core point of the article is that Huayang New Materials (SH 600281) held its 10th board meeting on November 19, 2025, to discuss a proposal for a working capital loan from Taiyuan Rural Commercial Bank, guaranteed by Taihua Real Estate Company [1] - For the fiscal year 2024, Huayang New Materials' revenue composition is as follows: precious metal processing accounts for 83.91%, biodegradable materials and products account for 12.1%, and other businesses account for 3.99% [1] - As of the time of reporting, Huayang New Materials has a market capitalization of 3.1 billion yuan [1]